Evidence map›Paper›PMID 42797334›Full record

ArticlePharmaceutics2026

Octreotide-Mediated Co-Solubilization of Paclitaxel and Docetaxel: A Novel Targeted Formulation for Synergistic Anticancer Chemotherapy.

Ahmed A H Abdellatif, Hesham M Tawfeek, Mahmoud Zaki El-Readi, Amani E Alharbi, Hamzah M Maswadeh, Mohammed A Amin, Safaa Y Eid, Abousree T Ellethy, Bassem Refaat, Akhmed Aslam and 2 more

Abstract read
In one paragraph

Article in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ahmed A H AbdellatifDepartment of Pharmaceutics, College of Pharmacy, Qassim University, Qassim 51452, Saudi Arabia.ORCID 0000-0002-3186-1896
Hesham M TawfeekDepartment of Industrial Pharmacy, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt.ORCID 0000-0001-9789-9953
Mahmoud Zaki El-ReadiDepartment of Biochemistry, Faculty of Medicine, Umm Al-Qura University, Al Abdeyah, Makkah 24381, Saudi Arabia.ORCID 0009-0007-0252-2370
Amani E AlharbiDepartment of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Madinah 42353, Saudi Arabia.ORCID 0000-0002-4356-2121
Hamzah M MaswadehDepartment of Pharmaceutics, College of Pharmacy, Qassim University, Qassim 51452, Saudi Arabia.ORCID 0000-0002-1218-2513
Mohammed A AminDepartment of Pharmaceutics, College of Pharmacy, Qassim University, Qassim 51452, Saudi Arabia.
Safaa Y EidDepartment of Biochemistry, Faculty of Medicine, Umm Al-Qura University, Al Abdeyah, Makkah 24381, Saudi Arabia.ORCID 0000-0003-3801-3715
Abousree T EllethyDepartment of Basic Oral Sciences and Dental Education, College of Dentistry, Qassim University, Buraidah 51452, Saudi Arabia.
Bassem RefaatDepartment of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Umm Al-Qura University, Al Abdeyah, P.O. Box 7607, Makkah 24381, Saudi Arabia.ORCID 0000-0003-4267-1016
Akhmed AslamDepartment of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Umm Al-Qura University, Al Abdeyah, P.O. Box 7607, Makkah 24381, Saudi Arabia.ORCID 0000-0002-0416-936X
Waleed Mohammad AltowayanDepartment of Pharmacy Practice, College of Pharmacy, Qassim University, Buraydah 52571, Saudi Arabia.ORCID 0000-0002-7719-9308
Mahmoud A YounisDepartment of Industrial Pharmacy, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt.ORCID 0000-0001-9722-3267

Funding

Qassim University QU-APC-2026
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancerclinical translationdocetaxeloctreotidepaclitaxel

Identifiers

PMID42797334
PMCPMC13610579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.